Literature DB >> 20959519

The origins and implications of intratumor heterogeneity.

Franziska Michor1, Kornelia Polyak.   

Abstract

Human tumors often display startling intratumor heterogeneity in various features including histology, gene expression, genotype, and metastatic and proliferative potential. This phenotypic and genetic heterogeneity plays an important role in neoplasia, cancer progression, and therapeutic resistance. In this issue of the journal (beginning on page 1388), Merlo et al. report their use of molecular data from 239 patients with Barrett's esophagus to evaluate the propensity of major diversity indices for predicting progression to esophageal adenocarcinoma. This work helps elucidate the implications of molecular heterogeneity for the evolution of neoplasia. ©2010 AACR.

Entities:  

Mesh:

Year:  2010        PMID: 20959519      PMCID: PMC3633425          DOI: 10.1158/1940-6207.CAPR-10-0234

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  31 in total

1.  Oligodendrocyte precursor cells reprogrammed to become multipotential CNS stem cells.

Authors:  T Kondo; M Raff
Journal:  Science       Date:  2000-09-08       Impact factor: 47.728

2.  Patterns of cell division and the risk of cancer.

Authors:  Steven A Frank; Yoh Iwasa; Martin A Nowak
Journal:  Genetics       Date:  2003-04       Impact factor: 4.562

Review 3.  Stem cells, cancer, and cancer stem cells.

Authors:  T Reya; S J Morrison; M F Clarke; I L Weissman
Journal:  Nature       Date:  2001-11-01       Impact factor: 49.962

4.  Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cells.

Authors:  Nikki Charles; Tatsuya Ozawa; Massimo Squatrito; Anne-Marie Bleau; Cameron W Brennan; Dolores Hambardzumyan; Eric C Holland
Journal:  Cell Stem Cell       Date:  2010-02-05       Impact factor: 24.633

Review 5.  Premalignant breast neoplasia: a paradigm of interlesional and intralesional molecular heterogeneity and its biological and clinical ramifications.

Authors:  Hal K Berman; Mona L Gauthier; Thea D Tlsty
Journal:  Cancer Prev Res (Phila)       Date:  2010-04-27

6.  A comprehensive survey of clonal diversity measures in Barrett's esophagus as biomarkers of progression to esophageal adenocarcinoma.

Authors:  Lauren M F Merlo; Najaf A Shah; Xiaohong Li; Patricia L Blount; Thomas L Vaughan; Brian J Reid; Carlo C Maley
Journal:  Cancer Prev Res (Phila)       Date:  2010-10-12

7.  An evolutionary model of carcinogenesis.

Authors:  Robert A Gatenby; Thomas L Vincent
Journal:  Cancer Res       Date:  2003-10-01       Impact factor: 12.701

8.  Somatic selection for and against cancer.

Authors:  Franziska Michor; Steven A Frank; Robert M May; Yoh Iwasa; Martin A Nowak
Journal:  J Theor Biol       Date:  2003-12-07       Impact factor: 2.691

9.  Evolutionary dynamics of mutator phenotypes in cancer: implications for chemotherapy.

Authors:  Natalia L Komarova; Dominik Wodarz
Journal:  Cancer Res       Date:  2003-10-15       Impact factor: 12.701

10.  Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype.

Authors:  So Yeon Park; Mithat Gönen; Hee Jung Kim; Franziska Michor; Kornelia Polyak
Journal:  J Clin Invest       Date:  2010-01-25       Impact factor: 14.808

View more
  79 in total

1.  First principles of Hamiltonian medicine.

Authors:  Bernard Crespi; Kevin Foster; Francisco Úbeda
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-03-31       Impact factor: 6.237

2.  Defects of the Carney complex gene (PRKAR1A) in odontogenic tumors.

Authors:  Sílvia F Sousa; Ricardo S Gomez; Marina G Diniz; Vanessa F Bernardes; Flávia F C Soares; João Artur R Brito; Sophie Liu; Hélder Antônio R Pontes; Constantine A Stratakis; Carolina C Gomes
Journal:  Endocr Relat Cancer       Date:  2015-04-13       Impact factor: 5.678

3.  Precise inference of copy number alterations in tumor samples from SNP arrays.

Authors:  Gary K Chen; Xiao Chang; Christina Curtis; Kai Wang
Journal:  Bioinformatics       Date:  2013-09-09       Impact factor: 6.937

Review 4.  Preclinical studies identify novel targeted pharmacological strategies for treatment of human malignant pleural mesothelioma.

Authors:  Roberto E Favoni; Antonio Daga; Paolo Malatesta; Tullio Florio
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

5.  PurBayes: estimating tumor cellularity and subclonality in next-generation sequencing data.

Authors:  Nicholas B Larson; Brooke L Fridley
Journal:  Bioinformatics       Date:  2013-06-06       Impact factor: 6.937

6.  Multivariate association analysis with somatic mutation data.

Authors:  Qianchuan He; Yang Liu; Ulrike Peters; Li Hsu
Journal:  Biometrics       Date:  2017-07-19       Impact factor: 2.571

Review 7.  How many molecular subtypes? Implications of the unique tumor principle in personalized medicine.

Authors:  Shuji Ogino; Charles S Fuchs; Edward Giovannucci
Journal:  Expert Rev Mol Diagn       Date:  2012-07       Impact factor: 5.225

Review 8.  The biology and mathematical modelling of glioma invasion: a review.

Authors:  J C L Alfonso; K Talkenberger; M Seifert; B Klink; A Hawkins-Daarud; K R Swanson; H Hatzikirou; A Deutsch
Journal:  J R Soc Interface       Date:  2017-11       Impact factor: 4.118

9.  High-throughput secretomic analysis of single cells to assess functional cellular heterogeneity.

Authors:  Yao Lu; Jonathan J Chen; Luye Mu; Qiong Xue; Yu Wu; Pei-Hsun Wu; Jie Li; Alexander O Vortmeyer; Kathryn Miller-Jensen; Denis Wirtz; Rong Fan
Journal:  Anal Chem       Date:  2013-02-01       Impact factor: 6.986

10.  Three-dimensional mRNA measurements reveal minimal regional heterogeneity in esophageal squamous cell carcinoma.

Authors:  Wusheng Yan; Joanna Shih; Jaime Rodriguez-Canales; Michael A Tangrea; Audrey Player; Lixia Diao; Nan Hu; Alisa M Goldstein; Jing Wang; Philip R Taylor; Scott M Lippman; Ignacio I Wistuba; Michael R Emmert-Buck; Heidi S Erickson
Journal:  Am J Pathol       Date:  2012-12-03       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.